Omniscope
Company

Last deal

$269.2K
Local Amount - EUR 248.K

Amount

Grant

Stage

01.06.2024

Date

7

all rounds

$7.9M

Total amount

General

About Company
Omniscope is a Deep Biotech that decodes the immune system using high-resolution sequencing and AI.

Industry

Sector :

Subsector :

founded date

25.02.2021

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

By combining immune cell sequencing and artificial intelligence, Omniscope's technology platforms provide high-definition repertoire profiles through their web-based Omniscope Immune Portal (OS-IP). This portal offers data and tools for discovery, enabling the development of diagnostics and informing therapy. With a mission to make healthcare accessible to all, Omniscope brings together experts from various fields, aiming to accelerate the translation of research into real-world human impact.
Contacts

Social url